Evaluación de la intervención farmacéutica en pacientes hospitalizados con nefropatías del Servicio de Medicina Interna del Hospital del IESS - Riobamba

Abstract

The Pharmaceutical intervention was evaluated in hospitalized patients with nephropathy at the Instituto Ecuatoriano de Seguridad Social-IESS of Riobamba in order to reduce drug-related problems by applying the DADER method, where the health status of each patient was analyzed through medical records; drug-related needs were evaluated through successive interviews and pharmacotherapeutic profile; the importance of the correct administration of drugs, nutrition, physical activity, among others, was explained. The study was carried out with a sample of 30 patients, comprising 36.7% women and 63.3% men, aged between 40 and 80 years in general; according to the second Granada Consensus of 2002 . Thirty-seven DRPs were identified, of which 45.9% (DRP 3) non-quantitative ineffectiveness of medication, 21.6% (DRP 1) lack of medication for untreated health problems, 10.6% (DRP 6) adverse reactions, 8.1% (DRP 2 and DRP 4) self-medication and inadequate doses, 5.4% (DRP 5) incidence of inadequate doses. It was concluded that the pharmaceutical intervention to the patient helped to solve the DRP, to the adequate use of the drugs to improve their effectiveness and safety, and showed greater adherence to the treatment, demonstrating an improvement in their quality of life. It is recommended to continue incorporating pharmaceutical care in primary care services because from there the pharmacist monitors the pharmacological therapy of the patient and thus avoids the progression of chronic pathologies and drug leaks.